Kenji Amagai

Effect of eradication of Helicobacter pylori on incidence of metachronous gastric carcinoma after endoscopic resection of early gastric cancer: an open-label, randomised controlled trial

Kazutoshi Fukase, Mototsugu Kato, Shogo Kikuchi et al. · The Lancet · 2008 · 1.2K citations

Gastrointestinal Oncology, Medicine, Gastroenterology +6

Phase III study comparing oxaliplatin plus S-1 with cisplatin plus S-1 in chemotherapy-naïve patients with advanced gastric cancer

Yasuhide Yamada, Katsuhiko Higuchi, Kazuhiro Nishikawa et al. · Annals of Oncology · 2014 · 524 citations · Full text

Chemotherapy-naïve Patients, Gastrointestinal Oncology, Advanced Gastric Cancer +8

Pembrolizumab plus chemotherapy versus placebo plus chemotherapy for HER2-negative advanced gastric cancer (KEYNOTE-859): a multicentre, randomised, double-blind, phase 3 trial

Sun Young Rha, Do‐Youn Oh, Patricio Yañez et al. · The Lancet Oncology · 2023 · 521 citations

Chemotherapy Versus Placebo, Gastrointestinal Oncology, Medicine +8

Phase III Trial Comparing Intraperitoneal and Intravenous Paclitaxel Plus S-1 Versus Cisplatin Plus S-1 in Patients With Gastric Cancer With Peritoneal Metastasis: PHOENIX-GC Trial

Hironori Ishigami, Yoshiyuki Fujiwara, Ryoji Fukushima et al. · Journal of Clinical Oncology · 2018 · 347 citations

Nab-paclitaxel versus solvent-based paclitaxel in patients with previously treated advanced gastric cancer (ABSOLUTE): an open-label, randomised, non-inferiority, phase 3 trial

Kohei Shitara, Atsuo Takashima, Kazumasa Fujitani et al. · ˜The œLancet. Gastroenterology & hepatology · 2017 · 215 citations

Gastrointestinal Oncology, Medicine, Advanced Gastric Cancer +5